The cell culture market size was valued at USD 22 billion in 2021 and is projected to reach USD 41 billion by 2030, expanding at a CAGR of around 12% during the forecast period, 2022 – 2030. The growth of the market is attributed to development of new three-dimensional cell culture methods and increased demand for these techniques in biopharmaceutical research and vaccine production.
Cell culture is the process of removing cells from plant or animal and growing them in a controlled environment. The cells can be extracted directly from the tissue and split using enzymatic or mechanical methods before being cultured, or they can be obtained from already established cell line or cell strain. In order to create a cell culture, several instruments and machines are used. These machines are known as instruments and several substances are used in the generation of cell cultures. These substances are used during manufacturing process thus, known as consumables. Cell culture requires conditions such as controlled physico-chemical environment, medium or substrate, gases, hormones, and growth factors.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing number of cancer patients and rising adoption of cell culture techniques are projected to drive the market.
- Rising awareness of the utilization of cell culture techniques in research is estimated to fuel the market.
- Growing cancer related research is one of the major factors driving the market
- Increased funding on research is expected to boost the market during the forecast period.
- Growing awareness about the advantages of cell-based vaccines is anticipated to propel the market during the projected period.
- High cost associated with cell biology research is projected to hamper the market growth.
- R&D investment and technological advancement in the field of cell culture is anticipated to create lucrative opportunities for the market players.
Scope of the Report
The report on the global cell culture market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Cell Culture Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2021
|
Historic Data
|
2019–2020
|
Forecast Period
|
2022 – 2030
|
Segmentation
|
Applications (Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Cancer Research, Stem Cell Technology, Vaccines, and Others), Products (Consumables [Media, Vessels, Reagent, and Serum] and Equipment [Incubator, Centrifuge, and Bioreactor]), End-users (Hospital, Biopharmaceuticals, Research Institutes, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Eppendorf; Promocell; Merck; Corning; Lonza; General Electric; Dickinson & Company; Becton; Thermo Fisher Scientific; Sartorius; Sigma-Aldrich Co.; Danaher Corporation; Agilent Technologies, Inc.; Miltenyi Biotec; Solida Biotech GmbH; Biospherix Ltd.; and SeraCare Life Sciences Inc.
|
Market Segment Insights
The drug development segment is projected to grow at a rapid pace during the forecast period
Based on applications, the market is segregated into tissue engineering & regenerative medicine, drug screening & development, cancer research, stem cell technology, vaccines, and others. The drug development segment is projected to grow at a rapid pace during the forecast period. The drug research process in the biotechnology sector is at peak, due to the COVID-19 outbreak. Several organizations and research institutions are working on coronavirus medicines and vaccinations. Cell culture is a crucial component of drug development and medical research. Due to the simplicity with which cell monolayers can be stimulated to grow on flat surfaces, two-dimensional (2D) culture has been the favored method for many decades. The cell culture industry has evolved, and 3D cell culture has recently emerged in the market. Drug development is an expensive and time-consuming process that involves several stages, including clinical trials, preclinical validation, lead discovery & optimization, and target identification, all of which culminate to approval for clinical usage.
The consumables segment dominated the market in 2021
On the basis of products, the market is bifurcated into consumables and equipment. The consumables segment is further segregated into media, vessels, reagent, and serum. The equipment segment is further divided into incubator, centrifuge, bioreactor. The consumables segment dominated the market in 2021. Increased vertical integration, development of the biopharmaceutical industry due to increased demand, and desire for alternate media are driving the cell culture market. The media sub-segment holds the major market share. When compared to average market costs for reagents and sera, media segment is significantly less expensive, and hence consumes a less portion of revenue despite having a big volume. With the rising need for culturing in cytological research projects, the segment is likely to see significant growth during the forecast period.
The biopharmaceuticals segment accounted for a major market share in 2021
In terms of end-users, the market is fragmented into hospital, biopharmaceuticals, research institutes, and others. The biopharmaceuticals segment accounted for a major market share in 2021. Growth of the segment is attributed to growing demand for non-conventional pharmaceuticals generated as a result of bio-production of proteomically and genetically modified drugs. Advancements in technology to culture and develop tissue from cells for use in grafting, as well as approaches for individualized genomic and proteomic surgical therapies are also estimated to fuel the market.
North America dominated the global market in 2021
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021 owing to presence of key market players and rising demand for customized medicine. Furthermore, the US government is cooperative of medical research, because healthcare is one of the country's top responsibilities.
Segments
The global cell culture market has been segmented on the basis of
Applications
- Tissue Engineering & Regenerative Medicine
- Drug Screening & Development
- Cancer Research
- Stem Cell Technology
- Vaccines
- Others
Products
- Consumables
- Media
- Vessels
- Reagent
- Serum
- Equipment
- Incubator
- Centrifuge
- Bioreactor
End-users
- Hospital
- Biopharmaceuticals
- Research Institutes
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Eppendorf
- Promocell
- Merck
- Corning
- Lonza
- General Electric
- Dickinson & Company
- Becton
- Thermo Fisher Scientific
- Sartorius
- Sigma-Aldrich Co.
- Danaher Corporation
- Agilent Technologies, Inc.
- Miltenyi Biotec
- Solida Biotech GmbH
- Biospherix Ltd.
- SeraCare Life Sciences Inc.
Competitive Landscape
Key players competing in the cell culture market include Eppendorf; Promocell; Merck; Corning; Lonza; General Electric; Dickinson & Company; Becton; Thermo Fisher Scientific; Sartorius; Sigma-Aldrich Co.; Danaher Corporation; Agilent Technologies, Inc.; Miltenyi Biotec; Solida Biotech GmbH; Biospherix Ltd.; and SeraCare Life Sciences Inc. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
- In January 2021, Captivate Bio introduced its cell culture toolkit to assist in the fight against COVID-19 and other emerging illnesses
- In March 2021, the Gibco Human Plasma-like Medium (HPLM) from Thermo Fisher Scientific is the first cell culture media that mimics the metabolic activity of human plasma.